Literature DB >> 23732458

Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD.

Vivekanand Jha1, Gopesh K Modi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23732458     DOI： 10.1038/nrneph.2013.104

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Accounting for the missing opportunity costs in incremental cost-outcome analysis.

Authors:  Adam Oliver
Journal:  Appl Health Econ Health Policy       Date:  2002       Impact factor: 2.561

2.  'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

Authors:  Allan J Collins; Robert N Foley; Blanche Chavers; David Gilbertson; Charles Herzog; Kirsten Johansen; Bertram Kasiske; Nancy Kutner; Jiannong Liu; Wendy St Peter; Haifeng Guo; Sally Gustafson; Brooke Heubner; Kenneth Lamb; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Bryn Thompson; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frank Daniels; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2012-01       Impact factor: 8.860

3.  Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

Authors:  Scott D Grosse
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2008-04       Impact factor: 2.217

4.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  BMJ       Date:  2013-03-25

5.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

6.  Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Authors:  Lawrence D Lazar; Mark J Pletcher; Pamela G Coxson; Kirsten Bibbins-Domingo; Lee Goldman
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

7.  Incorporating societal concerns for fairness in numerical valuations of health programmes.

Authors:  E Nord; J L Pinto; J Richardson; P Menzel; P Ubel
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

8.  Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Scott Klarenbach; Neesh Pannu; Matthew T James; Brenda R Hemmelgarn
Journal:  Lancet       Date:  2012-06-19       Impact factor: 79.321

9.  Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.

Authors:  Kevin F Erickson; Sohan Japa; Douglas K Owens; Glenn M Chertow; Alan M Garber; Jeremy D Goldhaber-Fiebert
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

Review 10.  Chronic kidney disease: global dimension and perspectives.

Authors:  Vivekanand Jha; Guillermo Garcia-Garcia; Kunitoshi Iseki; Zuo Li; Saraladevi Naicker; Brett Plattner; Rajiv Saran; Angela Yee-Moon Wang; Chih-Wei Yang
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321
  10 in total
  2 in total

Review 1.  Epidemiology of dyslipidemia in chronic kidney disease.

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2014-01-11       Impact factor: 2.801

2.  Outcome of live and deceased donor renal transplantation in patients aged ≥55 years: A single-center experience.

Authors:  V B Kute; A V Vanikar; P R Shah; M R Gumber; H V Patel; P R Modi; S J Rizvi; V R Shah; M P Modi; K V Kanodia; H L Trivedi
Journal:  Indian J Nephrol       Date:  2014-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.